Drugs / Fufangdanshen Tablets
Fufangdanshen Tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01761227 | Sep 2012 → Dec 2015 | vascular dementia | Dongzhimen Hospital, Beijing | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fufangdanshen Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01761227 ↗ |
| Known as | FFDS | “Fufangdanshen (FFDS) tablets (Radix Salviae miltiorrhizae formula tablets) are a traditional Chinese medicine” PMID 27266867 ↗ Jun 2016 |
| Known as | Fufangdanshen | “Fufangdanshen (FFDS) tablets (Radix Salviae miltiorrhizae formula tablets) are a traditional Chinese medicine” PMID 27266867 ↗ Jun 2016 |
| Known as | Radix Salviae miltiorrhizae formula tablets | “Fufangdanshen (FFDS) tablets (Radix Salviae miltiorrhizae formula tablets) are a traditional Chinese medicine” PMID 27266867 ↗ Jun 2016 |
| Modality | Traditional medicine (herbal / TCM) | “Fufangdanshen (FFDS) tablets (Radix Salviae miltiorrhizae formula tablets) are a traditional Chinese medicine” PMID 27266867 ↗ Jun 2016 |